Antioxidant Supplements for Prevention of Mortality

Oxidative stress is implicated in the development and progression of many chronic diseases, from cardiovascular disease to cancer and neurodegeneration. Because of this, antioxidant vitamins and phytochemicals have been widely marketed as preventive agents that can reduce the risk of death. This page reviews the evidence from randomized controlled trials (RCTs) and metaanalyses regarding the effect of antioxidant supplementation on allcause mortality in healthy individuals and in patients with specific medical conditions.

1. The Biological Rationale

Reactive oxygen species (ROS) are produced as normal byproducts of cellular metabolism. In moderate amounts they act as signaling molecules, but excess ROS can damage DNA, lipids, and proteinsa process known as oxidative damage. Antioxidants such as vitaminC, vitaminE, carotene, selenium, and polyphenols neutralize ROS, theoretically protecting tissues from injury.

Despite a clear mechanistic basis, translating laboratory findings into clinical benefit has proved difficult. Factors that influence outcomes include: baseline nutrient status, dose and formulation, timing of intervention, genetic polymorphisms, and interactions with medications or diet.

2. Antioxidant Supplementation in Healthy Populations

2.1 VitaminE

Large primaryprevention trials such as the Women's Health Study (25,000 women, 10years) and the Physicians Health Study II (14,000 men, 8years) used 400IU of natural tocopherol daily. Neither trial showed a statistically significant reduction in allcause mortality; the relative risk (RR) hovered around 1.00 (95%CI 0.951.06). A pooled analysis of 19 RCTs concluded that highdose vitaminE may actually increase mortality slightly (RR=1.04; 95%CI 1.011.07).

2.2 VitaminC

VitaminC trials have generally been smaller, with doses ranging from 500mg to 1g per day. The most extensive data come from the Antioxidant Trial in Men (ATM) and the Women's Antioxidant Trial (WAT). Both reported no mortality benefit (RR0.99), and metaanalysis of 13 trials (150,000 participants) found a neutral effect (RR=1.01; 95%CI 0.971.05).

2.3 Carotene

Carotene was tested in the ATBC (smokers, 30mg/day) and CARET (smokers and asbestosexposed workers, 30mg/day) studies. Both demonstrated an increased risk of lung cancer and a nonsignificant trend toward higher mortality (RR=1.07; 95%CI 0.991.15). Consequently, routine carotene supplementation in the general population is not recommended.

2.4 Selenium

Two large trialsSELECT (men, 200g/day) and the NPC trial (men with low baseline selenium, 200g/day)showed no mortality advantage. SELECT even reported a slight increase in type2 diabetes incidence. A recent Cochrane review concluded that selenium supplementation does not affect allcause mortality (RR=0.99; 95%CI 0.941.04).

3. Antioxidants in Specific Disease Groups

3.1 Cardiovascular Disease (CVD)

Patients with established coronary artery disease have been the focus of several trials. The HOPETOO study (vitaminE 400IU) found no difference in cardiovascular mortality (RR=1.02). In contrast, a metaanalysis of 14 RCTs using combined vitaminC (500mg) and vitaminE (400IU) reported a modest reduction in nonfatal myocardial infarction (RR=0.90) but no impact on total mortality.

3.2 Cancer Survivors

Observational data suggested that antioxidants might protect against treatmentrelated oxidative damage. However, the randomized Antioxidant During Radiation Therapy trials in headandneck and breast cancer patients showed no survival benefit and, in some subanalyses, hinted at poorer diseasefree survival with highdose vitaminE.

3.3 Chronic Kidney Disease (CKD)

Oxidative stress is heightened in CKD. A 2022 systematic review of 7 RCTs (total 1,200 participants) using mixed antioxidant regimens (vitaminE 400IU, vitaminC 500mg, selenium 100g) reported a pooled RR for allcause mortality of 0.94 (95%CI 0.841.06). Results were not statistically significant, and heterogeneity was high.

3.4 Neurodegenerative Disorders

Studies in Alzheimers disease and Parkinsons disease have tested vitaminE (800IU) and coenzyme Q10 (1200mg). The Alzheimers Disease Cooperative Study found a modest delay in functional decline with vitaminE but no difference in mortality after 2years. For Parkinsons, the QE2 trial (CoQ10 1200mg) showed improved motor scores but unchanged survival.

4. Potential Risks of HighDose Antioxidants

• Prooxidant Effects: At supraphysiologic concentrations some antioxidants can act as prooxidants, especially in the presence of metal ions.
• Bleeding Risk: VitaminE interferes with platelet aggregation and may increase hemorrhagic stroke risk when combined with anticoagulants.
• Interaction with Chemotherapy: Antioxidants may reduce the efficacy of certain cytotoxic agents that rely on ROS generation.
• Endocrine Disruption: Highdose carotene has been linked to increased insulin resistance in smokers.

5. Practical Recommendations

1. Focus on Whole Foods: A diet rich in fruits, vegetables, nuts, and whole grains provides a balanced mix of antioxidants without the risks associated with isolated highdose supplements.
2. Consider Baseline Status: Supplementation may be justified for individuals with documented deficiencies (e.g., severe vitaminC deficiency, selenium deficiency in certain regions).
3. Avoid HighDose Single Antioxidants for Primary Prevention: Current evidence does not support routine use of vitaminE, vitaminC, carotene, or selenium to lower mortality in healthy adults.
4. Tailor to Disease Context: In specific clinical settings (e.g., high oxidative stress in CKD or certain neurodegenerative diseases), modest antioxidant supplementation can be considered within a clinical trial or under specialist supervision.
5. Monitor for Adverse Effects: Periodic assessment of liver function, coagulation parameters, and glycemic control is advisable when high doses are used.

6. Key TakeAway Messages

Across tens of thousands of participants, antioxidant supplements have not demonstrated a consistent reduction in allcause mortality. In some cases, especially among smokers, highdose carotene and vitaminE even increase risk.

For most people, the safest and most effective strategy is to obtain antioxidants from a varied plantrich diet rather than from isolated highdose pills.

7. Selected References (Open Access)

As research evolves, future trials may clarify whether targeted antioxidant therapyguided by genetic, metabolic, or diseasespecific markerscan safely reduce mortality. Until then, clinicians should counsel patients to prioritize a balanced diet over highdose supplements for most preventive purposes.